FIBROBODIES
LIVE

Serial Number

90133236

Owner

LinXis B.V.

Attorney

Roberta S. Bren

Filing Date

Aug 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

FIBROBODIES Trademark

Serial Number: 90133236 • Registration: 6674974

FIBROBODIES is a trademark filed by LinXis B.V. on August 24, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LinXis B.V. (4 trademarks)

Cronenburg 152

Entity Type: 16

Trademark Details

Filing Date

August 24, 2020

Registration Date

March 22, 2022

Published for Opposition

August 24, 2021

Goods & Services

Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations

Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease

Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products

Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2025 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 22, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 22, 2024 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Feb 11, 2022 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 11, 2022 AITU
NOTICE OF ALLOWANCE CANCELLED
Jan 18, 2022 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jan 18, 2022 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 19, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 24, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2021 CRFA
ASSIGNED TO LIE
Jun 2, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2020 NWOS
NEW APPLICATION ENTERED
Aug 27, 2020 NWAP